TRPV1 suppressed KC proliferation by promoting the degradation of epidermal growth factor receptor (EGFR) and inhibiting the downstream AKT/GSK3β/FoxO3a pathway (Yoo et al., 2020). The gene discussed is EGFR; the disease is keratoconus.